6月12日至17日在瑞士日内瓦举行的世界贸易组织第12届部长级会议就新冠疫苗知识产权豁免达成部长决定。商务部称，在会议谈判的关键阶段，作为新冠疫苗生产和供应大国，中国主动宣布不寻求享受豁免决定所提供的灵活性，彰显了大国担当。

A major decision on the waiver of intellectual property rights for COVID-19 vaccines was made at the World Trade Organization's Ministerial Conference Twelfth Session (MC12) from June 12 to 17 in Geneva, Switzerland. At a pivotal stage of MC12 negotiations, China, as a major producer and a supplier of COVID-19 vaccines, announced that it will forego the flexibility of the Trade-Related Aspects of Intellectual Property Rights waiver on COVID-19 vaccines, which shows China's sense of responsibility as a major country, an official with the Ministry of Commerce said.

【重要讲话】

各国要相互支持，加强防疫措施协调，完善全球公共卫生治理，形成应对疫情的强大国际合力。要坚持疫苗作为全球公共产品的属性，确保疫苗在发展中国家的可及性和可负担性。

It is essential that countries support each other, better coordinate response measures and improve global public health governance, so as to form strong international synergy against the pandemic. We must keep COVID vaccines a global public good and ensure their accessibility and affordability in developing countries.

——2022年4月21日，习近平在博鳌亚洲论坛2022年年会开幕式上的主旨演讲

世界各国要加强国际抗疫合作，积极开展药物研发合作，共筑多重抗疫防线，加快建设人类卫生健康共同体。特别是要用好疫苗这个有力武器，确保疫苗公平分配，加快推进接种速度，弥合国际“免疫鸿沟”，把生命健康守护好、把人民生活保障好。

Countries need to strengthen international cooperation against COVID-19, carry out active cooperation on research and development of medicines, jointly build multiple lines of defense against the coronavirus, and speed up efforts to build a global community of health for all. Of particular importance is to fully leverage vaccines as a powerful weapon, ensure their equitable distribution, quicken vaccination and close the global immunization gap, so as to truly safeguard people's lives, health and livelihoods.

——2022年1月17日，习近平在世界经济论坛视频会议的演讲

【相关词汇】

人类卫生健康共同体

a global community of health for all

全球公共产品

global public good